EDITORIAL ADVISORY BOARD
The Editorial Advisory Board of Dissolution Technologies is a distinguished group of scientists active in fields and/or organizations related to dissolution testing. Members of the board review manuscripts and suggest subject matters relevant to dissolution testing.

CYNTHIA K. BROWN
Editorial Advisory Board Chair
Eli Lilly and Company

WILLIAM BROWN
USP

ROBERT G. BUICE, Ph.D.
Buice & Associates, LLC

JOHN R. CRISON, Ph.D.
Bristol-Myers Squibb

BRYAN CRIST
Agilent Technologies

DR. JENNIFER B. DRESSMAN
Johann Wolfgang Goethe - Universität
Frankfurt am Main, Germany

DAVID FORTUNATO
Johnson and Johnson

NIKOLETTA FOTAKI, Ph.D.
University of Bath, Bath, UK

VIVIAN A. GRAY
V.A. Gray Consulting, Inc.

SANDRA KLEIN, Ph.D.
Ernst Moritz Arndt University of Greifswald

JOHANNES KRÄMER, Ph.D.
PHAST

RAIMAR LÖBENBERG, Ph.D.
University of Alberta

PETRA LOOS, Ph.D.
Sanofi-Aventis

RUBEN LOZANO, Ph.D.
Bristol-Myers Squibb

XUJIN LU, Ph. D.
Bristol-Myers Squibb

MARGARETH R. C. MARQUES, Ph.D.
USP

RAKESH P. PATEL, Ph.D.
Ganpat University, Gujarat, India

JAMES E. POLLI, Ph.D.
University of Maryland

BRIAN R. ROHRS, Ph.D.
Bausch & Lomb

THOMAS W. ROSANSKE, Ph.D.
Acceleration Laboratory Services

PETER SCOTT
Dissolution Solutions

VINOD P. SHAH, Ph.D.
Pharmaceutical Consultant

DAVID C. SPERRY, Ph.D
Eli Lilly and Company

RODERICK B. WALKER, Ph. D.
Rhodes University, Grahamstown, South Africa